Brii Biosciences Limited (2137.HK)
HKD 0.85
(0.0%)
HKD 0.85
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.19 Billion CNY | -5.71% |
| 2022 | 3.39 Billion CNY | -6.09% |
| 2021 | 3.61 Billion CNY | 184.85% |
| 2020 | 1.26 Billion CNY | 21.99% |
| 2019 | 1.03 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.89 Billion CNY | 0.0% |
| 2024 Q1 | 2.89 Billion CNY | -9.43% |
| 2023 Q2 | 3.19 Billion CNY | 0.0% |
| 2023 FY | 3.19 Billion CNY | -5.71% |
| 2023 Q4 | 3.19 Billion CNY | 0.0% |
| 2023 Q3 | 3.19 Billion CNY | -0.0% |
| 2023 Q1 | 3.19 Billion CNY | -5.7% |
| 2022 Q2 | 3.47 Billion CNY | 0.0% |
| 2022 Q1 | 3.47 Billion CNY | -3.87% |
| 2022 FY | 3.39 Billion CNY | -6.09% |
| 2022 Q4 | 3.39 Billion CNY | 0.0% |
| 2022 Q3 | 3.39 Billion CNY | -2.3% |
| 2021 Q3 | 3.61 Billion CNY | 116.35% |
| 2021 FY | 3.61 Billion CNY | 184.85% |
| 2021 Q1 | 1.66 Billion CNY | 31.66% |
| 2021 Q2 | 1.66 Billion CNY | 0.0% |
| 2021 Q4 | 3.61 Billion CNY | 0.0% |
| 2020 FY | 1.26 Billion CNY | 21.99% |
| 2020 Q3 | 1.26 Billion CNY | 0.0% |
| 2020 Q4 | 1.26 Billion CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2019 FY | 1.03 Billion CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 409.99 Million HKD | -680.076% |
| CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 71.565% |